Corticosteroids for the management of ulcerative colitis and Crohn's disease.

Abstract

Corticosteroids are of proven value for the treatment of active ulcerative colitis and Crohn's disease, but are of little value for the maintenance of remission. The development of new steroid compounds with low systemic bioavailability should allow higher doses to be given for longer periods without risking serious adverse reactions. 

Topics

Cite this paper

@article{Jewell1989CorticosteroidsFT, title={Corticosteroids for the management of ulcerative colitis and Crohn's disease.}, author={Derek P. Jewell}, journal={Gastroenterology clinics of North America}, year={1989}, volume={18 1}, pages={21-34} }